Efficacy of Early Task-Oriented Rehabilitation in Acute Stroke Recovery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University

About this trial

Stroke is one of the leading causes of long-term disability worldwide, and early rehabilitation is considered crucial for improving functional recovery. Traditional physiotherapy mainly focuses on mobility, strength, and general exercises, while task-oriented rehabilitation emphasizes practicing meaningful, goal-directed activities related to daily life. This randomized controlled trial aims to evaluate the efficacy of early task-oriented rehabilitation compared to traditional rehabilitation in acute stroke patients. Patients admitted with ischemic or hemorrhagic stroke within 48 hours will be randomly assigned to either a task-oriented rehabilitation program or conventional physiotherapy. Interventions will be delivered 3-4 times per week, 45-60 minutes per session, during hospitalization and continued in outpatient follow-up. The primary outcome will be functional independence assessed at 3 months. Secondary outcomes will include stroke severity, quality of life, and patient-reported outcomes. The findings are expected to provide evidence for improving rehabilitation strategies in Egypt.

Eligibility criteria

Qualifiers

Acute ischemic or hemorrhagic stroke diagnosed clinically and confirmed by imaging.

Admission to hospital or referral to outpatient clinic within 48 hours after stroke onset.

Age ≥ 18 years.

Both sexes.

Disqualifiers

Severe stroke not suitable for rehabilitation.

Severe comorbidities (e.g., vital organ failure, malignancy).

Severe aphasia, or severe visual or auditory impairment interfering with training.

Severe upper limb spasticity (Modified Ashworth Scale > 3).

Trial design

Treatments tested in this trial

  • Task-Oriented Rehabilitation
  • Traditional Physiotherapy Rehabilitation

Treatment groups

158 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators